AH
Assort HealthAssort Health builds AI voice agents that automate patient access workflows for healthcare organizations, including scheduling, intake, referrals, and insurance verification.
2 Pulse stories
OB
Ollin BiosciencesClinical-stage biopharmaceutical company developing best-in-disease therapies for vision-threatening eye diseases, including a VEGF/Ang2 bispecific antibody in Phase 3 for DME and wet AMD.
2 Pulse stories
Total Raised
$222M
$430M
Assort HealthOllin Biosciences
Last Valuation
$1.2B
Assort HealthOllin Biosciences
Biotech
Sector
Biotech
2023
Founded
2023
San Francisco, California
HQ
Chicago, Illinois
Private
Status
Private
Assort Health investors
Menlo VenturesLightspeed Venture PartnersFelicisFirst Round CapitalChemistryLiquid 2 VenturesQuiet CapitalA* Capital
Ollin Biosciences investors
ARCH Venture PartnersTCGX (TCG Crossover)Andreessen HorowitzMubadala CapitalMonograph CapitalBlackstone Multi-Asset InvestingCommodore CapitalRA Capital Management
Data from Value Add Pulse coverage and company research — see the full threads for Assort Health and Ollin Biosciences.